6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Novel Psychoactive Substances and Emerging Drug Trends
Synthetic compounds that mimic traditional drugs but skirt legal frameworks are complicating addiction landscapes. The proliferation of novel psychoactive substances and emerging drug trends poses significant risks due to unpredictable potency and side effects. These substances often evade detection by standard drug screens, challenging clinicians during diagnosis and treatment. From synthetic cannabinoids to designer stimulants, their impact can be severe, leading to hospitalizations, psychosis, or fatal overdoses. Monitoring systems and toxicological advancements are now essential in keeping pace with new variants. Public awareness campaigns, rapid policy adaptation, and global data sharing are crucial to curbing the spread and harm of these unpredictable substances.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Jana Furstova
Palacký University Olomouc, Czech Republic
Alexander Kharibegashvil
Telavi State University, GeorgiaSubmit your abstract Today
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Integrative addiction and mental health wellness lecture
John Giordano, Life Enhancement Recovery Center, United States
Title : Step one therapy
Ashton Christopher, Center for Recovery, Canada
Title : Addiction rehabilitation & recovery: Pathways to healing and resilience
Sindu Padmanabhan, Bharathiar University, India
Title : Stress-induced trauma syndrome in Chinese teenagers
Daniel Sun, Westminster Theological Seminary, United States
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States